Vertex Pharmaceuticals, Inc. (VRTX)
463.48
-7.39
(-1.57%)
USD |
NASDAQ |
Feb 10, 16:00
462.43
-1.05
(-0.23%)
After-Hours: 07:13
Vertex Pharmaceuticals Market Cap : 117.59B for Feb. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 156.98B |
| Eli Lilly & Co. | 917.39B |
| Merck & Co., Inc. | 290.77B |
| Regeneron Pharmaceuticals, Inc. | 79.81B |
| Moderna, Inc. | 16.41B |
Market Cap Related Metrics
| PE Ratio | 32.67 |
| PS Ratio | 10.23 |
| Price to Book Value | 6.790 |
| Price to Free Cash Flow | 35.99 |
| Price | 463.48 |
| Earnings Yield | 3.06% |
| Operating PE Ratio | 26.52 |
| Normalized PE Ratio | 29.62 |